NCT03780634 HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC Status WITHDRAWN Phase PHASE2
NCT03780049 HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B Status UNKNOWN Phase PHASE3
NCT03778957 A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03777475 the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT03776123 Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients Status COMPLETED Phase N/A
NCT03775707 Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria Status WITHDRAWN Phase PHASE2
NCT03755791 Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03754192 Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT03752398 A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) Status COMPLETED Phase PHASE1
NCT03748927 Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma Status WITHDRAWN Phase N/A
NCT03744624 Application of 3D Printing in Laparoscopic Surgery of Liver Tumors Status UNKNOWN Phase NA
NCT03744247 Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC Status WITHDRAWN Phase PHASE3
NCT03739164 Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS) Status UNKNOWN Phase N/A
NCT03738111 Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE1
NCT03734926 A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT03734068 Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC Status UNKNOWN Phase N/A